Meet Stefan
Strategic Co-Pilot
for Cell Biology, Imaging & Lab Innovation
I’m Stefan Prechtl, a scientist turned consultant with over 20 years of experience in pharmaceutical R&D. I founded CELLIMA to support research teams like yours in building scalable, well-structured lab systems – especially where biology, imaging, and automation intersect.
How I Work
I guide research teams through strategic planning and prioritization
I bridge gaps between biology, technology, and data
I translate complexity into scalable, future-ready systems
Whether it’s a screening campaign, a Cell Painting setup, a 3D model implementation, or an HCI–AI integration – I help teams make informed, confident decisions across disciplines and development stages.
Why I Do What I Do
During my years in early-stage drug discovery, I realized that great technology alone doesn’t guarantee progress.
What research teams truly need is clarity:
in lab workflows
in interdisciplinary collaboration
and in decision-making about tools and processes.
So I shifted my focus from operating within systems to helping others build better ones.
How I Add Value
-
e.g. roadmap planning, feasibility assessment, cross-functional alignment for 3D-organoid facilities
-
e.g. defining interfaces between assay design, microscope control, and centralized data processing
-
e.g. bridging biology, AI, and lab operations for early-stage screening campaigns
-
hosting expert interviews that connect scientific trends with real lab challenges
What Others Say
“Stefan brought both scientific depth and structural clarity into our imaging setup – an ideal combination.”
Andrea Faedo, Head of Molecular and Cellular Biology Group
“Stefan’s extensive expertise in evaluating and selecting innovative high-content imaging approaches has been instrumental in advancing our drug discovery projects to the next level.”
Anke Müller-Fahrnow, VP, Senior Advisor Innovation Campus Berlin
“Stefan’s unmatched experience in live assay data provides insights into target and screen quality that are simply invaluable.”
Mike Snider, Former Director of Molecular Pharmacology at Berlex Biosciences
Want to see how science meets strategy?
Learn how I support research teams in structuring imaging, automation, and collaboration challenges